What's Going On With Tempus AI Shares Thursday?
I'm PortAI, I can summarize articles.
Tempus AI, Inc. (NASDAQ:TEM) shares rose 14.5% to $84.60 on Thursday following the announcement of a collaboration with the Institute for Follicular Lymphoma Innovation. This partnership aims to enhance targeted therapy development for follicular lymphoma by creating a multimodal data library within Tempus’ analytics platform, focusing on POD24 patients. Tempus is set to report its Q4 earnings for the 2024 fiscal year on February 24, with analysts predicting a loss of 20 cents per share and revenue of $203.12 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments